Comera Life Sciences to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference
18 November 2022 - 8:05AM
Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences
company developing a new generation of bio-innovative biologic
medicines to improve patient access, safety, and convenience, today
announced it will be participating in the Benchmark
Company’s 11th Annual Discovery One-on-One Investor Conference
to be held Thursday, December 1, 2022 at the New York Athletic Club
in New York.
Interested parties can access a copy of Comera’s current
investor presentation at: https://ir.comeralifesciences.com/
About Comera Life Sciences
Leading a compassionate new era in medicine, Comera Life
Sciences is applying a deep knowledge of formulation science and
technology to transform essential biologic medicines from
intravenous (IV) to subcutaneous (SQ) forms that can be
self-administered. The goal of this approach is to provide patients
with the freedom of self-injectable care, reduce institutional
dependency and to put patients at the center of their treatment
regimen.
To learn more about the Comera Life Sciences mission, as well as
the proprietary SQore™ platform, visit
https://comeralifesciences.com/.
Contacts:
Comera Investor
John WoolfordICR
WestwickeJohn.Woolford@westwicke.com
Comera Press
Jon YuICR WestwickeComeraPR@westwicke.com
Comera Life Sciences (NASDAQ:CMRA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Comera Life Sciences (NASDAQ:CMRA)
Historical Stock Chart
From Sep 2023 to Sep 2024